The harmonization of the regulation of blood products: A European perspective

Vox Sanguinis

Volumn 94, Issue 4, 2008, Pages 267-276

  Seitz, R ^a   Heiden, M ^a   Nubling C M ^a   Unger, G ^a   Lower J ^a  

^a PAUL EHRLICH INSTITUT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD; BLOOD COMPONENT; BLOOD TRANSFUSION; EUROPE; HEALTH CARE QUALITY; IN VITRO STUDY; LAW; MEDICAL LITERATURE; PLASMA; PRIORITY JOURNAL; REVIEW; RISK FACTOR; VIRUS TRANSMISSION; WORLD HEALTH ORGANIZATION;

BLOOD COMPONENT REMOVAL; BLOOD COMPONENT TRANSFUSION; CONSUMER PRODUCT SAFETY; EUROPE; HUMANS; INTERNATIONAL COOPERATION; MASS SCREENING; PHARMACOPOEIAS AS TOPIC; QUALITY CONTROL; SEROLOGIC TESTS;

EID: 42149190648     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/j.1423-0410.2007.01026.x     Document Type: Review

References (21)

1. Cohn EJ, Strong LE, Hughes WL, Jr., Mulford DJ, Ashworth JN, Melin M, Melin M, Taylor HL : Preparation and properties of serum and plasma proteins. IV: A system for the separation into fractions of the protein and lipoprotein components of biological tissues and fluid. Am J Chem Soc 1946 68 : 459 475
2. European Union : Consolidated versions of the treaty on European Union and of the treaty establishing the European Community. Official Journal of the European Union 2006 29.12.2006 : C 321 E/1 C 321 E/331. Available at http://eur-lex.europa.eu/LexUriServ/site/en/oj/2006/ce321/ ce32120061229en00010331.pdf
3. Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use. Official Journal of the European Communities 2001 28.11.2001 : L 311/67 L 311/128. Available at http://ec.europa.eu/enterprise/pharmaceuticals/eudralex/ vol-1/dir_2001_83/dir_2001_83_en.pdf
4. Council Directive 89/381/EEC of 14 June 1989 extending the scope of Directives 65/65/EEC and 75/319/EEC on the approximation of provisions laid down by law, regulation or administrative action relating to proprietary medicinal products and laying down special provisions for medicinal products derived from human blood or human plasma. Official Journal of the European Communities, 28.06.1989 : L 181/44 L 181, 46. Available at http://eur-lex.europa.eu/ LexUriServ/LexUriServ.do?uri=CELEX:31989L0381:EN:HTML
5. Guideline on the definition of a potential serious risk to public health in the context of Article 29(1) and (2) of Directive 2001/83/EC-March 2006. Official Journal of the European Union 2006 8.6.2006 : C 133/5 C 133/7. Available at http://ec.europa.eu/enterprise/pharmaceuticals/eudralex/vol-1/ com_2006_133/com_2006_133_en.pdf
6. Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March 2004 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency. Official Journal of the European Union 2004 30.4.2004 : L 136/1 L 136/33. Available at http://ec.europa.eu/enterprise/ pharmaceuticals/review/doc/final_publ/reg_2004_726_20040430_en.pdf
7. EudraLex - The Rules Governing Medicinal Products in the European Union. Available at http://ec.europa.eu/enterprise/pharmaceuticals/eudralex/index.htm
8. The European Agency for the Evaluation of Medicinal Products/Committee for Proprietary Medical Products (CPMP) Biotechnology Working Party : Note for Guidance on Plasma-Derived Medicinal Products, 2001. CPMP/BWP/269/95, rev.3, 25 January 2001. Available at http://www.emea.europa.eu/pdfs/human/bwp/026995en.pdf
9. Directive 2002/98/EC of the European Parliament and of the Council of 27 January 2003 setting standards of quality and safety for the collection, testing, processing, storage and distribution of human blood and blood components and amending Directive 2001/83/EC. Official Journal of the European Union 2003 8.2.2003 : L 33/30 L 33/40. Available at http://eur-lex.europa.eu/ LexUriServ/site/en/oj/2003/l_033/l_03320030208en00300040.pdf
10. Commission Directive 2004/33/EC of 22 March 2004 implementing Directive 2002/98/EC of the European Parliament and of the Council as regards certain technical requirements for blood and blood components. Official Journal of the European Union 2004 30.3.2004 : L 91/25 L 91/39. Available at http://eur-lex.europa.eu/pri/en/oj/dat/2004/l_091/l_09120040330en00250039.pdf
11. Commission Directive 2005/61/EC of 30 September 2005 implementing Directive 2002/98/EC of the European Parliament and of the Council as regards traceability requirements and notification of serious adverse reactions and events. Official Journal of the European Union 2005 1.10.2005 : L 256/32 L 256/40. Available at http://www.emea.europa.eu/pdfs/human/pdf/2005-61-EC.pdf
12. Commission Directive 2005/62/EC of 30 September 2005 implementing Directive 2002/98/EC of the European Parliament and of the Council as regards Community standards and specifications relating to a quality system for blood establishments. Official Journal of the European Union 2005 1.10.2005 : L 256/41-L 256/48. Available at http://www.emea.europa.eu/pdfs/human/pmf/2005-62- EC.pdf
13. Directive 98/79/EC of the European Parliament and of the Council of 27 October 1998 on in vitro diagnostic medical devices. Official Journal of the European Communities 1998 7.12.98 L 331/1 L 331/37. Available at http://eur-lex.europa.eu/LexUriServ/site/en/oj/1998/l_331/ l_33119981207en00010037.pdf
14. Commission Decision of 7 May 2002 on common technical specifications for in vitro-diagnostic medical devices. Official Journal of the European Communities 2002 16.5.2002 : L 131/17 L 131/30. Available at http://emea.europa.eu/pdfs/human/pmf/2002-364-EC.pdf
15. Council of Europe : Guide to the Preparation, Use and Quality Assurance of Blood Components, 13th edn. Strasbourg, France, Council of Europe Publishing, 2007
16. European Directorate for the Quality of Medicines of the Council of Europe (EDQM European Pharmacopoeia, 6th edn, Volume 2. Strasbourg, France : European Directorate for the Quality of Medicines of the Council of Europe (EDQM), 2007
17. Council of Europe : Human plasma for fractionation. Pharmeuropa 2006 18 : 103 104
18. WHO : WHO Requirements for the Collection, Processing and Quality Control of Blood, Blood Components and Plasma Derivatives. WHO Technical Report Series No. 840, Annex 2 (adopted by ECBS 1992). Geneva, Switzerland, World Health Organization, 1994
19. WHO : WHO Recommendations for the Production, Control and Regulation of Human Plasma for Fractionation. (Adopted by ECBS 2005), 2005. Available at http://www.who.int/biologicals/publications/ ECBS%202005%20Annex%204%20Human%20Plasma%20Fractionation.pdf
20. WHO : WHO Guidelines on Tissue Infectivity Distribution in Transmissible Spongiform Encephalopathies. WHO 2006 (adopted by ECBS 2005). Available at http://www.who.int/bloodproducts/tse/WHO%20TSE%20Guidelines%20FINAL- 22%20JuneupdatedNL.pdf
21. WHO : WHO Recommendations for the Preparation, Characterization and Establishment of International and Other Biological Reference Standards. WHO Technical Report Series (TRS) No 932, Annex 2 (adopted by ECBS 2004). Available at http://www.who.int/bloodproducts/publications/Final_Prep_Stds_Nov2004.pdf